Symposium 4 (HA): Advances in treatment for paediatric hypertension and obesity
Tracks
Track 4
| Wednesday, December 10, 2025 |
| 11:00 AM - 1:00 PM |
Details
This symposium will explore recent developments in the management of paediatric hypertension and obesity, two interlinked and increasingly prevalent conditions with significant long-term health implications. The session will open with a keynote address on emerging therapies for treatment-resistant hypertension, with opportunity for discussion about translation of state-of-the-art adult practices to paediatrics. The new Australian guidelines on the identification and management of high blood pressure in children will be presented, focusing on recommendations for therapy. Recognising the critical role of lifestyle modification, we will also discuss patient- and clinician-focused resources for implementing the DASH diet in paediatric populations. Finally, the symposium will cover innovative methods for managing childhood obesity, including new therapeutic options beyond lifestyle intervention. Together, these talks will provide a comprehensive overview of current and future strategies to improve cardiovascular health outcomes for young patients. The session will deliver a practical and forward-looking perspective for clinicians and researchers focused on improving cardiovascular outcomes in young populations.
Speaker
Prof Markus Schlaich
Dobney Hypertension Centre - Royal Perth Hospital - University of Western Australia
Emerging therapies for treatment resistant hypertension
Biography
Prof Markus Schlaich is a renal physician and a European Society of Hypertension (ESH) accredited hypertension specialist. Markus is Chair of Hypertension Australia and Co-Chair of the National Hypertension Taskforce. He has a strong background in clinical research with a focus on the pathophysiology of hypertension, the role of the sympathetic nervous system, involvement of the kidneys, and hypertension mediated organ damage. He has a specific interest in treatment modalities targeting the sympathetic nervous system and has been a pioneer of renal denervation and other interventional approaches. He has authored more than 475 articles in peer reviewed journals and serves on the Editorial Board of Hypertension, Journal of Hypertension, and Hypertension Research.
Dr Nicholas Larkins
Consultant Paediatric Nephrologist
Perth Children's Hospital
New Australian guidelines, when and how to manage high BP in children
Biography
Arielle Hyland
Senior Dietitian
Perth Children’s Hospital
DASH diet resource to support lifestyle intervention for paediatric hypertension
Biography
Dr Danielle Longmore
Consultant Paediatric Endocrinologist
Royal Children’s Hospital, Melbourne
Emerging methods for treating childhood obesity
Biography
Chair
Rae-Chi Huang
Edith Cowan University/Perth Children’s Hospital
Jonathan Mynard
Murdoch Children's Research Institute
